Abstract
The study’s objective was to establish the prevalence and variables associated with post-traumatic stress disorder risk (PTSD-R) in a sample of COVID-19 survivors in Santa Marta, Colombia. A cross-sectional study was designed with a non-probabilistic sample of adult COVID-19 survivors. Participants were demographically characterized and completed scales for depression risk, insomnia risk, and PTSD-R. Three hundred and thirty COVID-19 survivors between 18 and 89 years participated; 61.52% were women. The frequency of depression risk was 49.70%; insomnia risk, 60.61%; and PTSD-R, 13.33%. Depression risk (OR = 41.43, 95% CI 5.54 – 311.63), insomnia risk (OR = 5.25, 95% CI 1.77 – 18.71), low income (OR = 3.46, 95% CI 1.38 – 8.67) and being married or free union (OR = 2.65, 95% CI 1.13 – 6.22) were associated with PTSD-R. In conclusion, two out of every fifteen COVID-19 survivors are in PTSD-R. Depression and insomnia risk are strongly associated with PTSD-R in COVID-19 survivors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Universidad del Magdalena, Santa Marta, Colombia, funded the project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
THe Research Ethics Committee approved the study of the Universidad del Magdalena, Santa Marta, Colombia (Approval Certificate 002 of March 26, 2020).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: Universidad del Magdalena, Santa Marta, Colombia.
John Carlos Pedrozo-Pupo: participated in the collection of information, the interpretation and discussion of the results, the critical review, and approved the final version.
Edwin Herazo: participated in the statistical analysis, the interpretation, and discussion of the results, the critical review, and approved the final version.
Data availability statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
